These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 4009968)
1. The effects of myocardial perfusion with perfluorochemical substances. Tomoda H Jpn Heart J; 1985 Mar; 26(2):247-57. PubMed ID: 4009968 [TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of perfluorochemical artificial blood on cardiac function following coronary occlusion. Mushlin PS; Boucek RJ; Parrish MD; Graham TP; Olson RD Life Sci; 1985 Jun; 36(22):2093-102. PubMed ID: 3999916 [TBL] [Abstract][Full Text] [Related]
3. Crystalloid and perfluorochemical perfusates in an isolated working rabbit heart preparation. Chemnitius JM; Burger W; Bing RJ Am J Physiol; 1985 Aug; 249(2 Pt 2):H285-92. PubMed ID: 4025564 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of myocardial protection by isoflurane. Role of adenosine triphosphate-regulated potassium (KATP) channels. Kersten JR; Schmeling TJ; Hettrick DA; Pagel PS; Gross GJ; Warltier DC Anesthesiology; 1996 Oct; 85(4):794-807; discussion 27A. PubMed ID: 8873550 [TBL] [Abstract][Full Text] [Related]
5. Effects of intracoronary infusion of arterial blood or Fluosol-DA 20% on regional myocardial metabolism and function during brief coronary artery occlusions. Tokioka H; Miyazaki A; Fung P; Rajagopalan RE; Kar S; Meerbaum S; Corday E; Drury JK Circulation; 1987 Feb; 75(2):473-81. PubMed ID: 2948736 [TBL] [Abstract][Full Text] [Related]
6. Improvement of myocardial function by trifluoperazine, a calmodulin antagonist, after acute coronary artery occlusion and coronary revascularization. Otani H; Engelman RM; Rousou JA; Breyer RH; Clement R; Prasad R; Klar J; Das DK J Thorac Cardiovasc Surg; 1989 Feb; 97(2):267-74. PubMed ID: 2915562 [TBL] [Abstract][Full Text] [Related]
7. Relationship between hemodynamics and cardiac metabolism in the reperfusion period following hypothermic global ischemia. Sunamori M; Amano J; Suzuki A Jpn J Surg; 1981; 11(4):245-50. PubMed ID: 7289231 [TBL] [Abstract][Full Text] [Related]
8. The relationships of high energy phosphates, tissue pH, and regional blood flow to diastolic distensibility in the ischemic dog myocardium. Momomura S; Ingwall JS; Parker JA; Sahagian P; Ferguson JJ; Grossman W Circ Res; 1985 Dec; 57(6):822-35. PubMed ID: 4064257 [TBL] [Abstract][Full Text] [Related]
9. Perfluorochemical reperfusion limits myocardial reperfusion injury after prolonged hypothermic global ischemia. Martin SM; Laks H; Drinkwater DC; Stein DG; Barthel SW; Capouya ER; Pearl JM; Bhuta S; Ho B; Chang P Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):985-9. PubMed ID: 1391543 [TBL] [Abstract][Full Text] [Related]
10. Hemodilution and myocardial oxygen supply. The influence of fluosol-DA. Vogel H; Günther H; Harrison DK; Anderer W; Kessler M; Peter K Adv Exp Med Biol; 1989; 248():653-61. PubMed ID: 2782181 [No Abstract] [Full Text] [Related]
11. Effects of systemic hypertension on ischemic and nonischemic regional left ventricular function in awake, unsedated dogs after experimental coronary occlusion. Roan PG; Buja M; Saffer S; Izquierdo C; Hagler H; Duke B; Hillis LD; Willerson JT Circulation; 1982 Jan; 65(1):115-25. PubMed ID: 6796286 [TBL] [Abstract][Full Text] [Related]
12. [The experimental study on long-term cardiac preservation: the efficacy of low-flow continuous perfusion with fluorocarbon]. Umemoto M; Otani H; Omoto K; Tanaka K; Saitoh Y; Fukunaka M; Masuda A; Nonoyama A Nihon Kyobu Geka Gakkai Zasshi; 1989 Nov; 37(11):2328-38. PubMed ID: 2614114 [TBL] [Abstract][Full Text] [Related]
13. Treatment of postischemic reperfusion cardiac injury with a perfluorochemical solution. Parrish MD; Olson RD; Mushlin PS; Artman M; Boucek RJ J Cardiovasc Pharmacol; 1984; 6(1):159-64. PubMed ID: 6199599 [TBL] [Abstract][Full Text] [Related]
14. Tolerance of the hypertrophic heart to ischemia. Studies in compensated and failing dog hearts with pressure overload hypertrophy. Gaasch WH; Zile MR; Hoshino PK; Weinberg EO; Rhodes DR; Apstein CS Circulation; 1990 May; 81(5):1644-53. PubMed ID: 2139593 [TBL] [Abstract][Full Text] [Related]
15. Fluosol-DA: an artificial blood for total cardiopulmonary bypass. Engelman RM; Rousou JH; Dobbs WA Ann Thorac Surg; 1981 Dec; 32(6):528-35. PubMed ID: 7316587 [TBL] [Abstract][Full Text] [Related]
16. Effect of graded reductions in regional coronary perfusion on regional and total cardiac function. Wyatt HL; Forrester JS; Tyberg JV; Goldner S; Logan SE; Parmley WW; Swan HJ Am J Cardiol; 1975 Aug; 36(2):185-92. PubMed ID: 1155340 [TBL] [Abstract][Full Text] [Related]
17. Effects of artificial blood (FC-43 emulsion) on myocardial energy metabolism in the rat heart-lung preparation. Kashimoto S; Nakamura T; Nonaka A; Kume M; Oguchi T; Kumazawa T Br J Anaesth; 1994 Sep; 73(3):380-3. PubMed ID: 7946867 [TBL] [Abstract][Full Text] [Related]
18. Prevention of lactate production and myocyte injury in isolated rat hearts perfused with perfluorochemical emulsion. Rahamathulla PM; Watanabe K; Ashraf M; Millard RW Exp Pathol; 1985; 28(3):157-65. PubMed ID: 4065287 [TBL] [Abstract][Full Text] [Related]